CIBBIM-Nanomedicine

406 papers and 13.3k indexed citations i.

About

In recent decades, authors affiliated with CIBBIM-Nanomedicine have published 406 papers, which have received a total of 13.3k indexed citations. Scholars at this organization have produced 147 papers in Molecular Biology, 124 papers in Oncology and 74 papers in Cancer Research on the topics of Cancer Genomics and Diagnostics (36 papers), Cancer Immunotherapy and Biomarkers (28 papers) and Nanoparticle-Based Drug Delivery (23 papers). Their work is cited by papers focused on Molecular Biology (6.3k citations), Oncology (3.9k citations) and Cancer Research (2.7k citations). Authors at CIBBIM-Nanomedicine collaborate with scholars in Spain, United States and Italy and have published in prestigious journals including Science, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition. Some of CIBBIM-Nanomedicine's most productive authors include Simó Schwartz, Aleix Prat, Bárbara Adamo, Diego Arango, Jaume Alijotas‐Reig, Ibane Abasolo, Patricia Galván, Charles M. Perou, Ana Arance and José Raúl Herance.

In The Last Decade

Fields of papers published by authors at CIBBIM-Nanomedicine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with CIBBIM-Nanomedicine at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with CIBBIM-Nanomedicine at the time of their publication.

Countries citing scholars working at CIBBIM-Nanomedicine

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at CIBBIM-Nanomedicine. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at CIBBIM-Nanomedicine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CIBBIM-Nanomedicine more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025